| 1 |
33296106 | COVID-19, microthromboses, inflammation, and platelet activating factor. | 2020 Nov |
3 |
| 2 |
31470575 | Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications. | 2019 Aug 29 |
2 |
| 3 |
27758758 | Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). | 2017 |
9 |
| 4 |
26267219 | Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years. | 2016 Feb |
1 |
| 5 |
26120520 | Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects. | 2014 |
1 |
| 6 |
23826741 | Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. | 2013 Nov |
1 |
| 7 |
23869224 | Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents. | 2013 |
5 |
| 8 |
24267366 | Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor. | 2013 Dec |
1 |
| 9 |
24499312 | Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design. | 2013 Nov 1 |
3 |